It’s become a familiar message on the Island – that a company doesn’t have to be in Toronto or Montreal or Vancouver to be globally successful in the biotech sector. In this article posted in The Guardian Newspaper, BioAlliance Executive Director, Rory Francis talks about the growth of the PEI Bioscience Cluster.
Business View Magazine interviews Greg Boone, Founder and CEO of Dosecann Inc., for our focus on Canadian cannabis companies.
Incorporated in 2016, Dosecann Inc. is a Canadian licensed dealer dedicated to developing cannabis solutions for the global cannabis industry. Proudly located in Charlottetown, PEI, Dosecann has assembled a world-class team housed in a purpose-built, 42,000-sq.-ft. GMP-compliant facility in the BioCommons Research Park that will be the hub for cannabis extraction, product innovation and formulation, and manufacturing. Read full interview here
Dr. Laura Braden, an eminent sea lice researcher who now works for AquaBounty, lives on Prince Edward Island, Canada, with her husband-to-be, a young baby, two German shepherds and a Norwegian forest cat. Here, she explains how genetic engineering can help save the planet. Read full story here.
International Animal Health Journal, February 2018
Analysis of the proposed service fees for veterinary drug review and maintenance brings the CAHI to the conclusion that should this proposal come to be implemented, as is, sales for 58% of the current livestock products will not support a new registration, while 52% of companion animal product sales will not support introduction to the Canadian market. If innovation costs of 5% of the total R&D costs are included in the calculation, 79% of the livestock products (74% for companion animal) fall below the financial threshold to support product registration and launch in Canada.